Dyax dyax.com


Public lists: Rare Diseases (230)

Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development. Dyax also leverages this technology broadly with over 70 revenue generating licenses and collaborations for therapeutic discovery, as well as in non-core areas such as affinity separations, diagnostic imaging, and rese...Show all

Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide comp...Show all

Company (Acquired)

Phone: 617-225-2500

Fax: 617-225-2501

55 Network Drive

Burlington, 01803
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Dyax $48.8M Jan 22, 2016
See all 25 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Dyax Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Focus VenturesVenture CapitalPalo Alto, California, United StatesUnattributed VC
Alta PartnersVenture CapitalSan Francisco, California, United StatesUnattributed VC
Chase H&QUnattributed VC
GoldPoint PartnersPrivate EquityNew York, New York, United StatesUnattributed VC
BancBoston CapitalVenture CapitalBoston, Massachusetts, United StatesUnattributed VC
See all 12 investors

Competitors

Company Status Description Investors
See all 25 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Libraries of genetic packages comprising novel hc cdr3 designs Dec 08, 2017 Jul 21, 2020 Patent
Evaluation, assays and treatment of pkal-mediated disorders Jan 17, 2014 Jun 23, 2020 Patent
Libraries of genetic packages comprising novel hc cdr1, cdr2, and cdr3 and novel lc cdr1, cdr2, and cdr3 designs Jun 08, 2016 Jun 16, 2020 Patent
Diagnosis and treatment of autoimmune diseases Sep 14, 2018 May 12, 2020 Patent
Focused libraries of genetic packages Oct 30, 2017 Mar 31, 2020 Patent
See all 148 patents